Novel tubulin and tau neuroprotective fragments sharing structural similarities with the drug candidate NAP (Davuentide)

Illana Gozes*, Tal Iram, Evgenia Maryanovsky, Carmit Arviv, Liora Rozenberg, Yulie Schirer, Eliezer Giladi, Sharon Furman-Assaf

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

NAP (NAPVSIPQ, davunetide) is a microtubule stabilizing peptide drug candidate. Here, we set out to identify NAP-like peptides that provide neuroprotection and reduce tau pathology. NAP-like peptides were derived using publically available search engines, which identified sequence homologies in the microtubule subunit tubulin and in the microtubule associated protein, tau. NATLSIHQ (NAT) and STPTAIPQ were derived from tubulin, and TAPVPMPD (TAP) was derived from tau. All peptides provided neuroprotection against the Alzheimer's disease (AD) toxin, the amyloid-β 1-42 peptide, although NAT and TAP were much more potent than STPTAIPQ. NAT also protected astrocytes, while STPTAIPQ was active only at micromolar concentrations. Because NAT and TAP were much more potent than STPTAIPQ in neuroprotection, those peptides were also tested for inhibition of tau-like aggregation (the second protein hallmark pathology of AD). Both NAT and TAP inhibited tau-like aggregation, with NAT being active over a very broad concentration range. NAT also protected in vivo in a frontotemporal dementia transgenic mouse model (Tau-Tg), when tested at the age of ~10 months. Results showed significantly decreased levels of the NAP parent protein, activity-dependent neuroprotective protein in the cerebral cortex of the Tau-Tg which was increased back to normal levels by NAT treatment. This was coupled to protection of Brain-Body weight ratio in the compromised Tau-Tg. With AD being the major tauopathy and with tau taking part in frontotemporal dementia, novel NAP derivatives that reduce tauopathy and provide neuroprotection are of basic and clinical interest.

Original languageEnglish
Pages (from-to)S23-S36
JournalJournal of Alzheimer's Disease
Volume40
Issue numberS1
DOIs
StatePublished - 2014

Keywords

  • Activity-dependent neuroprotective protein (ADNP)
  • NAP (davunetide)
  • aggregation
  • microtubules
  • neuroprotection
  • peptides
  • tau
  • tauopathy
  • tubulin

Fingerprint

Dive into the research topics of 'Novel tubulin and tau neuroprotective fragments sharing structural similarities with the drug candidate NAP (Davuentide)'. Together they form a unique fingerprint.

Cite this